首页 | 本学科首页   官方微博 | 高级检索  
     

血清Apelin-13、可溶性血栓调节蛋白、锁链素对急性肺栓塞患者病情及预后的评估价值
引用本文:朱迎伟,褚旭,邱家勇,毛毅敏,孙瑜霞. 血清Apelin-13、可溶性血栓调节蛋白、锁链素对急性肺栓塞患者病情及预后的评估价值[J]. 临床肺科杂志, 2021, 26(2): 168-173
作者姓名:朱迎伟  褚旭  邱家勇  毛毅敏  孙瑜霞
作者单位:471003 河南 洛阳,河南科技大学第一附属医院呼吸与危重症医学科;471003 河南 洛阳,河南科技大学第一附属医院呼吸与危重症医学科;471003 河南 洛阳,河南科技大学第一附属医院呼吸与危重症医学科;471003 河南 洛阳,河南科技大学第一附属医院呼吸与危重症医学科;471003 河南 洛阳,河南科技大学第一附属医院呼吸与危重症医学科
基金项目:河南省医学科技攻关计划(联合共建项目)(No.2018020285);洛阳市青年医学科技创新联合专项基金项目(No.1503008A-8)。
摘    要:
目的 探究血清脂肪细胞因子13(Apelin-13)、可溶性血栓调节蛋白(sTM)、锁链素(DES)对急性肺栓塞(APE)患者病情及预后的评估价值.方法 选取我院2017年10月~2019年8月APE患者118例作为观察组,另选取同期健康体检者115例作为对照组.于两组入院时检测血清Apelin-13、sTM、DES水...

关 键 词:急性肺栓塞  Apelin-13  可溶性血栓调节蛋白  锁链素  预后

Value of serum Apelin-13,soluble thrombomodulin,and desmosine in the assessment of disease and prognosis of patients with acute pulmonary embolism
ZHU Ying-wei,CHU Xu,QIU Jia-yong,MAO Yi-min,SUN Yu-xia. Value of serum Apelin-13,soluble thrombomodulin,and desmosine in the assessment of disease and prognosis of patients with acute pulmonary embolism[J]. Journal of Clinical Pulmonary Medicine, 2021, 26(2): 168-173
Authors:ZHU Ying-wei  CHU Xu  QIU Jia-yong  MAO Yi-min  SUN Yu-xia
Affiliation:(Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Henan University of Science and Technology,Luoyang,Henan 471003,China)
Abstract:
Objective To investigate the value of serum adipokine 13(Apelin-13),soluble thrombomodulin(sTM),and desmosine(DES)in the evaluation of the condition and prognosis of patients with acute pulmonary embolism(APE).Methods From October 2017 to August 2019,118 patients with APE in our hospital were selected as the observation group,and 115 patients with healthy physical examination during the same period were selected as the control group.Serum Apelin-13,sTM,and DES levels were measured at the time of admission between the two groups,and the serum Apelin-13,sTM,and DES levels were compared between the two groups and patients with different disease degrees and different prognosis,and analyzed their correlation with the degree of disease.ROC curve was used to evaluate the prognostic value of serum Apelin-13,sTM,and DES,and Kaplan-Meier(KM)curve was used for survival analysis.Results The levels of serum Apelin-13,sTM and DES in the observation group were higher than those in the control group(P<0.05).Serum Apelin-13,sTM,and DES levels increased with the increase of disease severity(P<0.05).Spearman correlation analysis showed that serum Apelin-13(r=0.402),sTM(r=0.353),and DES(r=0.507)were positively correlated with disease severity(P<0.05).The serum levels of Apelin-13,sTM and DES at admission was higher in the death group than in the survival group(P<0.05).Logistic regression showed that serum Apelin-13,sTM and DES were significant prognostic factors(P<0.05).The AUC of serum Apelin-13,sTM,and DES combined for predicting prognosis was the highest(0.895),followed by DES(0.807),Apelin-13(0.728),and sTM(0.717),with a sensitivity of 80.00%and specificity of 87.18%.KM curve analysis showed that the survival rate of those with high expression of serum Apelin-13,sTM and DES was lower than that of those with low expression(P<0.05).Conclusion Serum Apelin-13,sTM and DES are closely related to the severity of APE,which is helpful to predict the prognosis and survival status,and provide a reliable reference for clinical diagnosis and treatment.
Keywords:acute pulmonary embolism  apelin-13  soluble thrombomodulin  desmosine  prognosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号